BI

Healthcare · Healthcare Research, Analytics & Technology

Bilcare Ltd (BI)

₹80.38

Mkt cap
₹182 Cr
P/E ratio
4.99
P/B
1.06
Div yield
0.00%
ROE
1.39%
ROCE
7.06%
EPS (TTM)
₹16.11
Book value
₹76
52W range
35–113
Sector
Healthcare

Price history

Previous close

Incorporated in 1987, Bilcare Ltd. is engaged in the business of Pharmaceutical Packaging, Global Clinical Services, R&D services and Anti Counterfeit Technology (nCid).

NSE BIBSE 526853
Health check
Cautious
ValuationCheap
ProfitabilityWeak
GrowthLow
TechnicalsNeutral
52-week range
−28.87% from high
₹80
₹35+129.66% from low₹113
Current
₹80.38
Prev close
₹82.07
Day
−2.06%
Price performance
1D
−2.06%
1W
−0.04%
1M
−7.69%
3M
−12.31%
6M
+28.38%
1Y
—
YTD
+26.19%

Financials

Revenue, profit & margin
P/E ratio
5.0×
BI is 80% below the sector median of 24.4×
BI5.0×
Sector median24.4×
 Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026Trend
Sales189.92174.94200.07194.14201.74198.13194.03186.36178.20181.32187.66225.86248.43
YoY Sales growth-25.24%-28.85%-14.35%+6.52%+6.22%+13.26%-3.02%-4.01%-11.67%-8.48%-3.28%+21.20%+39.41%
Expenses173.22157.69208.33175.20194.09187.47186.35175.29174.78168.31170.73188.84226.12
Operating Profit16.7017.25-8.2618.947.6510.667.6811.073.4213.0116.9337.0222.31
OPM %8.79%9.86%-4.13%9.76%3.79%5.38%3.96%5.94%1.92%7.18%9.02%16.39%8.98%
Other Income0.563.768.823.74-6.02-6.4721.166.084.323.3412.460.013.53
Interest19.6620.5422.5920.8523.6819.4818.6818.5519.0617.0417.6918.0819.73
Depreciation10.4810.5713.4011.5211.0411.744.6611.565.315.014.784.114.13
Profit before tax-12.88-10.10-35.43-9.69-33.09-27.035.50-12.96-16.63-5.706.9214.841.98
Tax %-5.36%34.06%-44.48%55.01%-9.55%-39.92%-119.27%-24.69%-1.38%3.33%-13.44%-0.88%45.96%
Net Profit-12.19-13.54-19.67-15.02-29.93-16.2412.06-9.76-16.40-5.897.8514.971.07
EPS in Rs-3.22-2.91-4.63-2.71-6.81-3.047.47-1.61-2.310.415.685.391.75
Raw PDF

Earnings

Results dates & reactions
No upcoming results date on calendar.

Fresh quarters land in the Financials table above, tagged NSE until screener catches up.

No reaction history yet.
No quarterly filings ingested yet.

Corporate actions

Last 6 months

No recent corporate actions

Dividends, splits, and bonuses in the last six months show up here.

Shareholding

as of Sep 2026
30.01%Promoter
Promoters30.01%
FIIs0.04%
Public69.95%0.01
Ownership trend

Peers

8 companies
Valuation vs quality
P/E × ROCE · bubble = market cap
NameCMPP/EMkt CapDiv YldNP QtrQtr Profit VarSales QtrQtr Sales VarROCE
Syngene Intl.₹451.7068.5518,2230.28%32−45.17%833−8.55%9.99%
Indegene₹657.6537.1715,8540.34%112+9.99%1,122+39.55%18.82%
Suven Life Scie.₹269.40—7,6370.00%−107−38.33%1+30.43%−79.54%
Vimta Labs₹467.6525.702,0940.43%21+3.46%112+9.95%25.23%
Fabtech Tech.₹140.3720.996250.43%15−67.06%92−24.19%13.88%
Take₹13.6923.152020.00%2+450.79%29—18.52%
Novelix Pharma.₹65.3740.021860.00%2+194.34%45+23.02%10.87%
Bilcare₹76.844.991820.00%1+175.74%248+39.41%7.06%
Median: 9 Co.₹140.3724.426250.00%3+9.99%92+26.73%10.87%

Filings